Review: implications of in vitro research on the effect of radiotherapy and chemotherapy under hypoxic conditions.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  The Oncologist

• Publication date

  2007-06-01

• Fields of study

  Medicine, Environmental Science

• Identifiers
  DOI 10.1634/THEONCOLOGIST.12-6-690PMID 17602059
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Expression of vascular endothelial growth factor (VEGF) in locally invasive prostate cancer is prognostic for radiotherapy outcome.

  2007cited by this paper
• Hypoxia and HIF-1alpha protect A549 cells from drug-induced apoptosis.

  2006cited by this paper
• Influence of irinotecan and SN-38 on the irradiation response of WHO3 human oesophageal tumour cells under hypoxic conditions.

  2006cited by this paper
• Hypoxia-inducible transcription factor-1α promotes hypoxia-induced A549 apoptosis via a mechanism that involves the glycolysis pathway

  2006cited by this paper
• Endogenous markers of two separate hypoxia response pathways (hypoxia inducible factor 2 alpha and carbonic anhydrase 9) are associated with radiotherapy failure in head and neck cancer patients recruited in the CHART randomized trial.

  2006cited by this paper
• HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption.

  2006cited by this paper
• Hypoxia-induced resistance to cisplatin and doxorubicin in non-small cell lung cancer is inhibited by silencing of HIF-1alpha gene.

  2006cited by this paper
• Knockdown of hypoxia-inducible factor-1alpha in breast carcinoma MCF-7 cells results in reduced tumor growth and increased sensitivity to methotrexate.

  2006cited by this paper
• HIF-1-mediated expression of pyruvate dehydrogenase kinase: a metabolic switch required for cellular adaptation to hypoxia.

  2006cited by this paper
• Prognostic significance of [18F]-misonidazole positron emission tomography-detected tumor hypoxia in patients with advanced head and neck cancer randomly assigned to chemoradiation with or without tirapazamine: a substudy of Trans-Tasman Radiation Oncology Group Study 98.02.

  2006cited by this paper
• The critical role of caspases activation in hypoxia/reoxygenation induced apoptosis.

  2006cited by this paper
• Reversing Hypoxic Cell Chemoresistance in Vitro Using Genetic and Small Molecule Approaches Targeting Hypoxia Inducible Factor-1

  2006cited by this paper
• Hypoxia signalling in cancer and approaches to enforce tumour regression

  2006cited by this paper
• Tumor hypoxia and cancer progression.

  2006cited by this paper
• Hypoxia-induced resistance to cisplatin and doxorubicin in non-small cell lung cancer is inhibited by silencing of HIF-1α gene

  2006cited by this paper
• Hypoxia stimulates breast carcinoma cell invasion through MT1-MMP and MMP-2 activation

  2006cited by this paper
• Hypoxia protects HepG2 cells against etoposide-induced apoptosis via a HIF-1-independent pathway.

  2006cited by this paper
• Does the tumor microenvironment influence radiation-induced apoptosis?

  2006cited by this paper
• Hypoxia confers protection against apoptosis via PI3K/Akt and ERK pathways in lung cancer cells.

  2006cited by this paper
• Lysyl oxidase is essential for hypoxia-induced metastasis

  2006cited by this paper
• Over expression of hypoxia-inducible factor-1alpha in renal and bladder cancer cells increases tumorigenic potency.

  2005cited by this paper
• Hypoxia-induced radioresistance is independent of hypoxia-inducible factor-1A in vitro.

  2005cited by this paper
• Enhanced response to radiotherapy in tumours deficient in the function of hypoxia-inducible factor-1.

  2005cited by this paper
• Phase III trial of paclitaxel plus carboplatin with or without tirapazamine in advanced non-small-cell lung cancer: Southwest Oncology Group Trial S0003.

  2005cited by this paper
• Genetic instability and the tumor microenvironment: towards the concept of microenvironment-induced mutagenesis.

  2005cited by this paper
• Functionality of hypoxia-induced BAX expression in a human glioblastoma xenograft model

  2005cited by this paper
• Hypoxia augments gelatinase activity in a variety of adenocarcinomas in vitro.

  2005cited by this paper
• Plasma osteopontin, hypoxia, and response to the hypoxia sensitiser nimorazole in radiotherapy of head and neck cancer: results from the DAHANCA 5 randomised double-blind placebo-controlled trial.

  2005cited by this paper
• HIF-1alpha attenuates tumor growth in spite of augmented vascularization in an A549 adenocarcinoma mouse model.

  2005cited by this paper
• Hypoxia‐Induced Acidification Causes Mitoxantrone Resistance Not Mediated by Drug Transporters in Human Breast Cancer Cells

  2005cited by this paper
• Hypoxia-selective activation of 5-fluorodeoxyuridine prodrug possessing indolequinone structure: radiolytic reduction and cytotoxicity characteristics.

  2005cited by this paper
• The tumor bed effect: increased metastatic dissemination from hypoxia-induced up-regulation of metastasis-promoting gene products.

  2005cited by this paper
• Effects of hypoxia on radiation-responsive stress-activated protein kinase, p53, and caspase 3 signals in TK6 human lymphoblastoid cells.

  2005cited by this paper
• Hypoxia level and matrix metalloproteinases-2 and -9 activity in Lewis lung carcinoma: correlation with metastasis.

  2005cited by this paper
• The relationship between hypoxia and angiogenesis.

  2004cited by this paper
• Cell type-specific association of hypoxia-inducible factor-1 alpha (HIF-1 alpha) protein accumulation and radiobiologic tumor hypoxia.

  2004cited by this paper
• Phase III Trial of Radiosensitizer PR-350 Combined With Intraoperative Radiotherapy for the Treatment of Locally Advanced Pancreatic Cancer

  2004cited by this paper
• A novel cancer therapy: combined liposomal hypoxia inducible factor 1 alpha antisense oligonucleotides and an anticancer drug.

  2004cited by this paper
• Ser/Thr Protein Phosphatase 5 Inactivates Hypoxia-induced Activation of an Apoptosis Signal-regulating Kinase 1/MKK-4/JNK Signaling Cascade*

  2004cited by this paper
• Anoxia/reoxygenation down-regulates the expression of E-cadherin in human colon cancer cell lines.

  2004cited by this paper
• Hypoxia and anemia: factors in decreased sensitivity to radiation therapy and chemotherapy?

  2004cited by this paper
• HIF-1alpha induces cell cycle arrest by functionally counteracting Myc.

  2004cited by this paper
• The role of hypoxia inducible factor 1 (HIF-1) in hypoxia induced apoptosis

  2004cited by this paper
• HIF‐1α induces cell cycle arrest by functionally counteracting Myc

  2004cited by this paper
• Prospects for hypoxia-activated anticancer drugs.

  2004cited by this paper
• The hypoxic tumour microenvironment and metastatic progression

  2004cited by this paper
• Hypoxia-Mediated Down-Regulation of Bid and Bax in Tumors Occurs via Hypoxia-Inducible Factor 1-Dependent and -Independent Mechanisms and Contributes to Drug Resistance

  2004cited by this paper
• Enhancement of Hypoxia-Induced Tumor Cell Death In vitro and Radiation Therapy In vivo by Use of Small Interfering RNA Targeted to Hypoxia-Inducible Factor-1α

  2004cited by this paper
• Hypoxia Inhibits Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand-Induced Apoptosis by Blocking Bax Translocation

  2004cited by this paper
• Influence of hypoxia on TRAIL-induced apoptosis in tumor cells.

  2004cited by this paper
• Cobalt chloride-induced apoptosis and extracellular signal-regulated protein kinase 1/2 activation in rat C6 glioma cells.

  2004cited by this paper
• Autocrine erythropoietin signaling inhibits hypoxia-induced apoptosis in human breast carcinoma cells.

  2004cited by this paper
• Neuroblastoma survival and death: an in vitro model of hypoxia and metabolic stress.

  2004cited by this paper
• Hypoxia Increases Resistance of Human Pancreatic Cancer Cells to Apoptosis Induced by Gemcitabine

  2004cited by this paper
• Role of hypoxia-inducible factor 1alpha in gastric cancer cell growth, angiogenesis, and vessel maturation.

  2004cited by this paper
• Cell type–specific association of hypoxia-inducible factor-1α (HIF-1α) protein accumulation and radiobiologic tumor hypoxia

  2004cited by this paper
• In vitro and in vivo evaluation of novel antitumor prodrugs of 5-fluoro-2'-deoxyuridine activated by hypoxic irradiation.

  2004cited by this paper
• Effects of Paclitaxel and Docetaxel on EGFR-Expressing Human Carcinoma Cells Under Normoxic Versus Hypoxic Conditions In Vitro

  2004cited by this paper
• Hypoxia-inducible factor 1alpha is essential for cell cycle arrest during hypoxia.

  2003cited by this paper
• Hypoxia-induced cell death in human malignant glioma cells: energy deprivation promotes decoupling of mitochondrial cytochrome c release from caspase processing and necrotic cell death

  2003cited by this paper
• ROS‐dependent caspase‐9 activation in hypoxic cell death

  2003cited by this paper
• Structure−Activity Relationships of 1,2,4-Benzotriazine 1,4-Dioxides as Hypoxia-Selective Analogues of Tirapazamine

  2003cited by this paper
• Necrosis and Hypoxia in Invasive Breast Carcinoma

  2003cited by this paper
• Levels of hypoxia‐inducible factor‐1α independently predict prognosis in patients with lymph node negative breast carcinoma

  2003cited by this paper
• Structure-activity relationships of 1,2,4-benzotriazine 1,4-dioxides as hypoxia-selective analogues of tirapazamine.

  2003cited by this paper
• Evaluation of hypoxia-inducible factor-1alpha (HIF-1alpha) as an intrinsic marker of tumor hypoxia in U87 MG human glioblastoma: in vitro and xenograft studies.

  2003cited by this paper
• Carbonic anhydrase IX expression, a novel surrogate marker of tumor hypoxia, is associated with a poor prognosis in non-small-cell lung cancer.

  2003cited by this paper
• Efficacy of cytotoxic agents used in the treatment of testicular germ cell tumours under normoxic and hypoxic conditions in vitro

  2003cited by this paper
• Combining bioreductive drugs and radiation for the treatment of solid tumors.

  2003cited by this paper
• Chronic hypoxia protects against gamma-irradiation-induced apoptosis by inducing bcl-2 up-regulation and inhibiting mitochondrial translocation and conformational change of bax protein.

  2003cited by this paper
• Apoptosis-resistance of hypoxic cells: multiple factors involved and a role for IAP-2.

  2003cited by this paper
• Hypoxia‐induced irreversible S‐phase arrest involves down‐regulation of cyclin A

  2003cited by this paper
• Genes commonly upregulated by hypoxia in human breast cancer cells MCF-7 and MDA-MB-231.

  2003cited by this paper
• Hypoxia-inducible factors HIF-1alpha and HIF-2alpha in head and neck cancer: relationship to tumor biology and treatment outcome in surgically resected patients.

  2002cited by this paper
• Hypoxia as a target for combined modality treatments.

  2002cited by this paper
• Regulation of Endothelial Matrix Metalloproteinase-2 by Hypoxia/Reoxygenation

  2002cited by this paper
• Role of angiogenesis in tumor growth and metastasis.

  2002cited by this paper
• Tumor hypoxia has independent predictor impact only in patients with node-negative cervix cancer.

  2002cited by this paper
• Expression of the angiopoietins and their receptor Tie2 in human renal clear cell carcinomas; regulation by the von Hippel‐Lindau gene and hypoxia

  2002cited by this paper
• Hypoxic prostate/muscle pO2 ratio predicts for biochemical failure in patients with prostate cancer: preliminary findings.

  2002cited by this paper
• Rescue of hypoxia-inducible factor-1alpha-deficient tumor growth by wild-type cells is independent of vascular endothelial growth factor.

  2002cited by this paper
• Increased radiosensitivity with chronic hypoxia in four human tumor cell lines.

  2002cited by this paper
• Modulation of growth and radiochemosensitivity of human malignant glioma cells by acidosis

  2002cited by this paper
• A nitroimidazole derivative, PR-350, enhances the killing of pancreatic cancer cells exposed to high-dose irradiation under hypoxia.

  2002cited by this paper
• Anoxia-induced apoptosis occurs through a mitochondria-dependent pathway in lung epithelial cells.

  2002cited by this paper
• Bcl-2 Family Members and Functional Electron Transport Chain Regulate Oxygen Deprivation-Induced Cell Death

  2002cited by this paper
• Hypoxia-inducible factor (HIF1A and HIF2A), angiogenesis, and chemoradiotherapy outcome of squamous cell head-and-neck cancer.

  2002cited by this paper
• Hypoxia-inducible factor-1-dependent regulation of the multidrug resistance (MDR1) gene.

  2002cited by this paper
• Hypoxia promotes lymph node metastasis in human melanoma xenografts by up-regulating the urokinase-type plasminogen activator receptor.

  2002cited by this paper
• The chemopotentiation of cisplatin by the novel bioreductive drug AQ4N

  2001cited by this paper
• Effect of hypoxia on cellular adhesion to vitronectin and fibronectin.

  2001cited by this paper
• In vivo evaluation of a novel antitumor prodrug, 1-(2'-oxopropyl)-5-fluorouracil (OFU001), which releases 5-fluorouracil upon hypoxic irradiation.

  2001cited by this paper
• The von Hippel-Lindau Gene Product Inhibits Renal Cell Apoptosis via Bcl-2-dependent Pathways*

  2001cited by this paper
• Hypoxia in human soft tissue sarcomas: Adverse impact on survival and no association with p53 mutations

  2001cited by this paper
• Hypoxia Induces the Activation of the Phosphatidylinositol 3-Kinase/Akt Cell Survival Pathway in PC12 Cells

  2001cited by this paper
• Activation of c-Jun NH2-terminal kinase/stress-activated protein kinase (JNK/SAPK) is critical for hypoxia-induced apoptosis of human malignant melanoma.

  2001cited by this paper
• Oxygen-mediated regulation of gelatinase and tissue inhibitor of metalloproteinases-1 expression by invasive cells.

  2001cited by this paper
• Up-regulation of Apoptosis Inhibitory Protein IAP-2 by Hypoxia

  2001cited by this paper
• p21Cip1 and p27Kip1Regulate Cell Cycle Reentry after Hypoxic Stress but Are Not Necessary for Hypoxia-Induced Arrest

  2001influential reference
• Expression of hypoxia-inducible factor-1alpha: a novel predictive and prognostic parameter in the radiotherapy of oropharyngeal cancer.

  2001cited by this paper

• The gene expression alterations in chronic hypoxic PANC-1 pancreatic cancer cell line

  2026cites this paper
• Comprehensive analysis of cellular heterogeneity in the tumor microenvironment reveals TUBG1 as an immunosuppressive regulator in hepatocellular carcinoma

  2025cites this paper
• Necrosis as a fundamental driver of loss of resilience and biological decline: what if we could intervene?

  2025cites this paper
• Treatment planning evolution: Comparing approaches in photodynamic and radiation therapies

  2025cites this paper
• Hypoxia-Driven Changes in Tumor Microenvironment: Insights into Exosome-Mediated Cell Interactions

  2024cites this paper
• Development of Anticancer Ferric Complex Based on Human Serum Albumin Nanoparticles That Generate Oxygen in Cells to Overcome Hypoxia-Induced Resistance in Metal Chemotherapy.

  2024cites this paper
• Dynamics analysis and optimal control of a fractional-order lung cancer model

  2024cites this paper
• Recent Progress in Anti-Tumor Nanodrugs Based on Tumor Microenvironment Redox Regulation.

  2024cites this paper
• Partial Acquisition of Spectral Projections Accelerates Four-dimensional Spectral-spatial EPR Imaging for Mouse Tumor Models: A Feasibility Study

  2024cites this paper
• Perturbation of Copper Homeostasis Sensitizes Cancer Cells to Elevated Temperature

  2023cites this paper
• A fractional-order mathematical model for lung cancer incorporating integrated therapeutic approaches

  2023cites this paper
• A study on lung cancer using nabla discrete fractional-order model

  2023cites this paper
• Significance of Specific Oxidoreductases in the Design of Hypoxia-Activated Prodrugs and Fluorescent Turn off–on Probes for Hypoxia Imaging

  2022cites this paper
• Modelling the effect of vascular status on tumour evolution and outcome after thermal therapy

  2022cites this paper
• Inhibition of ABCC9 by zinc oxide nanoparticles induces ferroptosis and inhibits progression, attenuates doxorubicin resistance in breast cancer

  2022influential citation
• The Photosensitizer Temoporfin (mTHPC) – Chemical, Pre‐clinical and Clinical Developments in the Last Decade † ‡

  2022cites this paper
• In vitro radiosensitization of breast cancer with hypoxia‐activated prodrugs

  2022cites this paper
• β-arrestin 2 stimulates degradation of HIF-1α and modulates tumor progression of glioblastoma

  2021cites this paper
• Gene network analysis to determine the effect of hypoxia-associated genes on brain damages and tumorigenesis using an avian model

  2021cites this paper
• Photodynamic Therapy—Current Limitations and Novel Approaches

  2021cites this paper
• Application of Advanced Mass Spectrometry-Based Proteomics to Study Hypoxia Driven Cancer Progression

  2021cites this paper
• Modulating the Heat Stress Response to Improve Hyperthermia-Based Anticancer Treatments

  2021cites this paper
• Stimulus-responsive liposomes for biomedical applications.

  2021cites this paper
• Mechanisms of Cetuximab Resistance and How to Overcome It

  2021cites this paper
• Towards Tumor Targeting via Invasive Assay Using Magnetospirillum magneticum

  2021cites this paper
• Intrabody Targeting HIF-1α Mediates Transcriptional Downregulation of Target Genes Related to Solid Tumors

  2021cites this paper
• Hyperthermia can alter tumor physiology and improve chemo- and radio-therapy efficacy.

  2020cites this paper
• Influence of oxygen level in colorectal tumor progression and response under different radiotherapy dose scheme

  2020cites this paper
• Emerging role of NRF2 in ROS-mediated tumor chemoresistance.

  2020cites this paper
• Pyridinium derivatives of 3-aminobenzenesulfonamide are nanomolar-potent inhibitors of tumor-expressed carbonic anhydrase isozymes CA IX and CA XII.

  2020cites this paper
• Organelle-localized radiosensitizers.

  2020cites this paper
• A pure molecular drug hydrogel for post-surgical cancer treatment.

  2020cites this paper
• Chaperonin Hsp60 and Cancer Therapies

  2020cites this paper
• Polyoxometalate-Based Nanomaterials Toward Efficient Cancer Diagnosis and Therapy.

  2020cites this paper
• A moderate thermal dose is sufficient for effective free and TSL based thermochemotherapy.

  2020cites this paper
• Recent advances in photonanomedicines for enhanced cancer photodynamic therapy

  2020cites this paper
• Chlorella-gold nanorods hydrogels generating photosynthesis-derived oxygen and mild heat for the treatment of hypoxic breast cancer.

  2019cites this paper
• Extremely effective chemo-radiotherapy by inducing immunogenic cell death and radio-triggered drug release under hypoxia alleviation.

  2019cites this paper
• Synthesis and evaluation of the HIF-1α inhibitory activity of 3(5)-substituted-4-(quinolin-4-yl)- and 4-(2-phenylpyridin-4-yl)pyrazoles as inhibitors of ALK5.

  2019cites this paper
• Hsp60 in Cancer Immunity: Biological Basis, Diagnostic Potential and Therapeutic Opportunities

  2019cites this paper
• Constitutive or Induced HIF-2 Addiction is Involved in Resistance to Anti-EGFR Treatment and Radiation Therapy in HNSCC

  2019cites this paper
• Iron in the biology and treatment of gastrointestinal cancer

  2019cites this paper
• Dynamics of oxygen level-driven regulators in modulating autophagy in colorectal cancer cells.

  2019cites this paper
• Catalase-like metal–organic framework nanoparticles to enhance radiotherapy in hypoxic cancer and prevent cancer recurrence

  2019cites this paper
• Overcoming Intrinsic and Acquired Cetuximab Resistance in RAS Wild-Type Colorectal Cancer: An In Vitro Study on the Expression of HER Receptors and the Potential of Afatinib

  2019cites this paper
• Hypoxia Induced Chemo-Resistance of Aggressive Central Giant Cell Granulomas and Their Treatment Options based on Cytogenetic Analysis of Bcl2 Gene

  2018cites this paper
• Simultaneous targeting of EGFR, HER2, and HER4 by afatinib overcomes intrinsic and acquired cetuximab resistance in head and neck squamous cell carcinoma cell lines

  2018cites this paper
• Low dose-rate irradiation with [3H]-labelled valine to selectively target hypoxic cells in a human colorectal cancer xenograft model

  2018cites this paper
• Near‐Infrared Upconversion Mesoporous Cerium Oxide Hollow Biophotocatalyst for Concurrent pH‐/H2O2‐Responsive O2‐Evolving Synergetic Cancer Therapy

  2018cites this paper
• Overcoming tumor hypoxia as a barrier to radiotherapy, chemotherapy and immunotherapy in cancer treatment

  2018cites this paper
• Anaemia and its effects on tumour regression grade and survival following chemotherapy in adenocarcinoma of the oesophagus.

  2018influential citation
• 6 Anticancer Drug Metabolism : Chemotherapy Resistance and New Therapeutic Approaches

  2018cites this paper
• A High Throughput Device for Clonogenic Assays and Radiobiology Research

  2018cites this paper
• Advances in Cancer Therapy 162 2 . Epidemiology , pathology and prognosis of patients with brain metastasis

  2017cites this paper
• Shikonin suppresses proliferation and induces cell cycle arrest through the inhibition of hypoxia-inducible factor-1α signaling.

  2017cites this paper
• Electric Cell-Substrate Impedance Sensing of Cellular Effects under Hypoxic Conditions and Carbonic Anhydrase Inhibition

  2017cites this paper
• Preclinical data on the combination of cisplatin and anti-CD70 therapy in non-small cell lung cancer as an excellent match in the era of combination therapy

  2017cites this paper
• Clinicopathologic and prognostic significance of immunohistochemical expression of HIF-1α, CXCR4 and CA9 in colorectal carcinoma.

  2017cites this paper
• Hypoxia modulates the stem cell population and induces EMT in the MCF-10A breast epithelial cell line

  2017cites this paper
• Dual Targeting of Epidermal Growth Factor Receptor and HER3 by MEHD7945A as Monotherapy or in Combination with Cisplatin Partially Overcomes Cetuximab Resistance in Head and Neck Squamous Cell Carcinoma Cell Lines

  2017cites this paper
• Value of Intratumoral Metabolic Heterogeneity and Quantitative 18F-FDG PET/CT Parameters to Predict Prognosis in Patients With HPV-Positive Primary Oropharyngeal Squamous Cell Carcinoma

  2017cites this paper
• Towards Prognostic Profiling of Non-Small Cell Lung Cancer: New Perspectives on the Relevance of Polo-Like Kinase 1 Expression, the TP53 Mutation Status and Hypoxia

  2017cites this paper
• Development of the Implantable Resonator System for Clinical EPR Oximetry

  2017cites this paper
• Obstrüktif Uyku Apnesi ve Kanser

  2016cites this paper
• Whole Brain Radiotherapy and RRx-001: Two Partial Responses in Radioresistant Melanoma Brain Metastases from a Phase I/II Clinical Trial12

  2016cites this paper
• An Implantable Depot That Can Generate Oxygen in Situ for Overcoming Hypoxia-Induced Resistance to Anticancer Drugs in Chemotherapy.

  2016cites this paper
• Hypoxia in Gliomas: Opening Therapeutical Opportunities Using a Mathematical-Based Approach.

  2016cites this paper
• Altered pH gradient at the plasma membrane of osteosarcoma cells is a key mechanism of drug resistance

  2016cites this paper
• Evaluation of CAIX and CAXII Expression in Breast Cancer at Varied O2 Levels: CAIX is the Superior Surrogate Imaging Biomarker of Tumor Hypoxia

  2016cites this paper
• VHL-deficient renal cancer cells gain resistance to mitochondria-activating apoptosis inducers by activating AKT through the IGF1R-PI3K pathway

  2016cites this paper
• Hypoxia on the Expression of Hepatoma Upregulated Protein in Prostate Cancer Cells

  2016cites this paper
• Targeted, triggered drug delivery to tumor and biofilm microenvironments.

  2016cites this paper
• PET AND MRI-GUIDED FOCUSED ULTRASOUND SURGERY FOR HYPOXIC-TISSUE ABLATION COMBINED WITH RADIOTHERAPY IN SOLID TUMORS

  2015cites this paper
• Curcumin in Cosmetics: Biochemical Basis for Skin Repair with Use of Topical Curcumin

  2015cites this paper
• Chapter 13 – Drug Targeting in Anticancer Chemotherapy

  2015cites this paper
• Radiation enhancing effects of sanazole and gemcitabine in hypoxic breast and cervical cancer cells in vitro

  2015cites this paper
• Effects of oxygen on the antigenic landscape of prostate cancer cells

  2015cites this paper
• Cyclometalated Ruthenium(II) Anthraquinone Complexes Exhibit Strong Anticancer Activity in Hypoxic Tumor Cells.

  2015cites this paper
• Cinnamic aldehyde suppresses hypoxia-induced angiogenesis via inhibition of hypoxia-inducible factor-1α expression during tumor progression.

  2015cites this paper
• Conséquences de l'hypoxie sur la régulation de la signalisation HGF/SF-MET

  2015cites this paper
• Gene expression alterations in chronic hypoxic MCF7 breast cancer cell line.

  2014cites this paper
• Carbonic anhydrase IX as an imaging and therapeutic target for tumors and metastases.

  2014cites this paper
• Synthesis and structure-activity relationships of novel, potent, orally active hypoxia-inducible factor-1 inhibitors.

  2014cites this paper
• Obstructive sleep apnea is associated with cancer mortality in younger patients.

  2014cites this paper
• Co-expression of CD147 and GLUT-1 indicates radiation resistance and poor prognosis in cervical squamous cell carcinoma.

  2014cites this paper
• The radiosensitising effect of gemcitabine and its main metabolite dFdU under low oxygen conditions is in vitro not dependent on functional HIF-1 protein

  2014cites this paper
• Sleep apnoea and cancer: the new challenge

  2014cites this paper
• Co-expression of CD 147 and GLUT1 indicates radiation resistance and poor prognosis in cervical squamous cell carcinoma

  2014cites this paper
• Obstructive sleep apnea and the prevalence and incidence of cancer

  2014cites this paper
• Intratumoral Metabolic Heterogeneity for Prediction of Disease Progression After Concurrent Chemoradiotherapy in Patients with Inoperable Stage III Non-Small-Cell Lung Cancer

  2014cites this paper
• Intermittent hypoxia with or without hypercapnia is associated with tumorigenesis by decreasing the expression of brain derived neurotrophic factor and miR‐34a in rats

  2014cites this paper
• Construction of oxygen and chemical concentration gradients in a single microfluidic device for studying tumor cell-drug interactions in a dynamic hypoxia microenvironment.

  2013cites this paper
• Radiation enhancing effects with the combination of sanazole and irinotecan in hypoxic HeLa human cervical cancer cell line.

  2013cites this paper
• CDK1 stabilizes HIF-1α via direct phosphorylation of Ser668 to promote tumor growth

  2013cites this paper
• Biliverdin reductase plays a crucial role in hypoxia-induced chemoresistance in human glioblastoma.

  2013cites this paper
• Aspects of γ-radiation induced modification of calf thymus DNA in the presence of sodium 1,4-dihydroxy-9,10-anthraquinone-2-sulfonate and its transition metal complexes with Cu2+ and Ni2+

  2013cites this paper
• Anti-epidermal growth factor receptor therapy in head and neck squamous cell carcinoma: focus on potential molecular mechanisms of drug resistance.

  2013cites this paper
• Influence of LET and oxygen status on cell survival and adhesion molecule expression

  2012cites this paper
• Complications and Toxicity After Abdominal and Pelvic Hypoxic Stop-Flow Perfusion Chemotherapy: Incidence and Assessment of Risk Factors

  2012cites this paper
• Synthesis and characterization of a hypoxia-sensitive MRI probe.

  2012cites this paper